Ureaplasma urealyticum overview

Revision as of 01:51, 21 April 2017 by Fatimo Biobaku (talk | contribs)
Jump to navigation Jump to search

Ureaplasma urealyticum Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ureaplasma urealyticum from other Bacteria

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Ureaplasma urealyticum overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ureaplasma urealyticum overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ureaplasma urealyticum overview

CDC on Ureaplasma urealyticum overview

Ureaplasma urealyticum overview in the news

Blogs on Ureaplasma urealyticum overview

Directions to Hospitals Treating Rhinitis

Risk calculators and risk factors for Ureaplasma urealyticum overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Ureaplasma species (U. urealyticum and U. parvum) are commensal organisms commonly found in the urogenital tract of sexually active men and women.[1] These organisms are considered to be of low virulence although several studies have demonstrated an association between vaginal colonization by Ureaplasma species and adverse pregnancy outcomes including perinatal morbidity and mortality.[2][3][4][5] Some studies also show an association between urogenital colonization by U. urealyticum and nongonococcal urethritis in men.[6][7][8] However, the pathogenic role of Ureaplasma urealyticum in nongonococcal urethritis is still not clear.[9][10][11] Colonization with Ureaplasma species occur in asymptomatic and symptomatic infants and adults, and further investigations to determine the exact pathogenic role of Ureaplasma is required.[5] There is often a medical dilemma as to whether an isolation of Ureaplasma represent a 'true' infection or 'mere' colonization. Hence, the challenge in making a decision whether medical treatment is necessary.

Historical Perspective

T-strain mycoplasma (now known as Ureaplasma urealyticum) was first discovered in the human urogenital tract in 1954 by Shepard et al.[10][7] Tiny(T)-strain mycoplasma was renamed Ureaplasma urealyticum in 1974.[10][7]

Classification

U. urealyticum was previously classified into two biotypes:[7][10]

  • Biovar 1 ( parvo biovar): Ureaplasma urealyticum biovar 1 is now known as U. parvum.
  • Biovar 2 (T960 biovar): Ureaplasma urealyticum biovar 2 strain retained its designation as U. urealyticum.

Pathophysiology

Ureaplasma raises the pH of the vagina by hydrolyzing urea into carbon dioxide and ammonia, increasing the susceptibility to mixed infection with other pathogenic bacteria.[5] These pathogens stimulate the secretion of pro-inflammatory cytokines and chemokines, leading to the recruitment of leukocytes and production of prostaglandins which subsequently result in preterm birth.[1][5] Vertical transmission of Ureaplasma has also been associated with neonatal complications such asPneumonitis, bacteremia, and meningitis following stimulation of fetal inflammatory responses by the organism.[12][13] Some studies conducted in men show there is an association between urogenital colonization by Ureaplasma urealyticum and nongonococcal urethritis, however, the pathogenic role of Ureaplasma urealyticum in nongonococcal urethritis is still not clear.[6][7][8][9][10][11]

Causes

Ureaplasma species are bacteria belonging to the family Mycoplasmataceae.

Differentiating Ureaplasma from other Diseases

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

History and Symptoms

Physical Examination

Laboratory Findings

X ray

CT

Other Diagnostic Studies

Medical Therapy

Surgery

References

  1. 1.0 1.1 Waites KB, Schelonka RL, Xiao L, Grigsby PL, Novy MJ (2009). "Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis". Semin Fetal Neonatal Med. 14 (4): 190–9. doi:10.1016/j.siny.2008.11.009. PMID 19109084.
  2. Waites KB, Crouse DT, Cassell GH (1993). "Systemic neonatal infection due to Ureaplasma urealyticum". Clin Infect Dis. 17 Suppl 1: S131–5. PMID 8399903  8399903 Check |pmid= value (help).
  3. Waites KB, Crouse DT, Philips JB, Canupp KC, Cassell GH (1989). "Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn". Pediatrics. 83 (1): 79–85. PMID 2909979  2909979 Check |pmid= value (help).
  4. Resch B, Gutmann C, Reiterer F, Luxner J, Urlesberger B (2016). "Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics". Infection. 44 (3): 323–7. doi:10.1007/s15010-015-0858-7. PMID 26518581.
  5. 5.0 5.1 5.2 5.3 Harada K, Tanaka H, Komori S, Tsuji Y, Nagata K, Tsutsui H; et al. (2008). "Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses". Microbiol Immunol. 52 (6): 297–304. doi:10.1111/j.1348-0421.2008.00039.x. PMID 18577163.
  6. 6.0 6.1 Povlsen K, Bjørnelius E, Lidbrink P, Lind I (2002). "Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis". Eur J Clin Microbiol Infect Dis. 21 (2): 97–101. PMID 11939406.
  7. 7.0 7.1 7.2 7.3 7.4 Deguchi T, Yoshida T, Miyazawa T, Yasuda M, Tamaki M, Ishiko H; et al. (2004). "Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis". Sex Transm Dis. 31 (3): 192–5. PMID 15076934.
  8. 8.0 8.1 Maeda S, Deguchi T, Ishiko H, Matsumoto T, Naito S, Kumon H; et al. (2004). "Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization". Int J Urol. 11 (9): 750–4. doi:10.1111/j.1442-2042.2004.00887.x. PMID 15379939.
  9. 9.0 9.1 Couldwell DL, Gidding HF, Freedman EV, McKechnie ML, Biggs K, Sintchenko V; et al. (2010). "Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men". Int J STD AIDS. 21 (5): 337–41. doi:10.1258/ijsa.2009.009499. PMID 20498103.
  10. 10.0 10.1 10.2 10.3 10.4 Shimada Y, Ito S, Mizutani K, Sugawara T, Seike K, Tsuchiya T; et al. (2014). "Bacterial loads of Ureaplasma urealyticum contribute to development of urethritis in men". Int J STD AIDS. 25 (4): 294–8. doi:10.1177/0956462413504556. PMID 24047884.
  11. 11.0 11.1 Esen B, Gozalan A, Sevindi DF, Demirbas A, Onde U, Erkayran U; et al. (2017). "Ureaplasma urealyticum: Presence among Sexually Transmitted Diseases". Jpn J Infect Dis. 70 (1): 75–79. doi:10.7883/yoken.JJID.2015.258. PMID 27000449.

Template:WH Template:WS